How is PCT used?

Procalcitonin (PCT) has been used to evaluate the risk of progression to sepsis and septic shock in critically ill patients and 28-day mortality risk after diagnosis. Now the Elecsys® BRAHMS PCT assay may be used to support antibiotic treatment decisions in patients with suspected or confirmed lower respiratory tract infections (LRTI), defined as acute exacerbations of chronic obstructive pulmonary disease (aeCOPD), community-acquired pneumonia (CAP) and acute bronchitis, and aid in antibiotic discontinuation in patients with suspected or confirmed sepsis.

Executive Summary

Today, fighting infections and managing antibiotic use go hand in hand. By adding procalcitonin (PCT) testing to lab and treatment protocols, healthcare systems could improve patient outcomes and potentially reduce the costs of care for certain bacterial infections and sepsis while curtailing unnecessary antibiotic use.1

Five Rivers Medical Center is one healthcare organization that has benefited from using PCT to fight infection and manage antibiotic use. It has:

   

LOWERED MORTALITY RATES

   

CUT COSTS FOR CARE

   

REDUCED UNNECESSARY USE OF ANTIBIOTICS
Related Stories
Huntsville Hospital

VIDEO

Expanding hospital outreach serves the community — and the bottom line

See how one hospital increased laboratory annual billables and reduced costs, enabling it to expand services for the community.

More stories are on the way.
Want to be the first to get the scoop?
Share your contact information. 
Success
Form submitted successfully
text